Expression of CD44v6 Gene in Normal Human Peripheral Blood
Overview
Authors
Affiliations
Aim: To investigate if CD44v6 could be used as a molecular marker of cancer progression and metastasis through the detection of CD44v6 gene expression in normal human peripheral blood.
Methods: RNA was extracted from the peripheral blood mononuclear cells of 50 healthy donors, the expression of CD44v6 was investigated using reverse transcriptase-polymerase chain reaction (RT-PCR).
Results: CD44v6 mRNA was detected in 58% of healthy volunteers under the proper controls.
Conclusion: Our results suggest that the measurement of CD44v6 expression in peripheral blood by RT-PCR is not suitable for detection of circulating tumor cells.
CD44v6 Defines a New Population of Circulating Tumor Cells Not Expressing EpCAM.
Belthier G, Homayed Z, Grillet F, Duperray C, Vendrell J, Krol I Cancers (Basel). 2021; 13(19).
PMID: 34638450 PMC: 8508506. DOI: 10.3390/cancers13194966.